According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

Bain Capital already owns nearly 40 percent of the Tennessee-based company’s stock. An analyst thinks other potential buyers ...

Bain Capital Specialty Finance (NYSE:BCSF – Get Free Report) had its price target lifted by analysts at Wells Fargo & Company from $17.00 to $18.00 in a research note issued to investors on Wednesday, ...

BOSTON - Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a business development company with a market capitalization of $1 ...